Sema4 (SMFR) Stock Analysis

What Sema4 does

Sema4 Holdings Corp., known in the market as Sema4, functions as a health information enterprise committed to leveraging data to enhance the diagnosis, treatment, and prevention of illnesses. A primary offering is Centrellis, an AI-driven health intelligence platform that furnishes extensive insights to biopharmaceutical firms, thereby streamlining the entire lifecycle of drug discovery, development, and commercialization. Centrellis further provides practical analytics, assistance for pre-clinical and clinical trials, and state-of-the-art sequencing capabilities. The company also markets Sema4 Signal, a product designed to facilitate and advance precise oncology care, covering everything from prevention strategies to active treatment and managing remission. Additionally, their diagnostic services encompass carrier screening, non-invasive prenatal assessments, newborn screening, and hereditary cancer testing, complemented by their COVID-19 testing solutions. Sema4 Holdings Corp. was established in 2020 and is based in Stamford, Connecticut.

Key metrics

ETFs linked to SMFR

Broad-market and Healthcare sector ETFs an investor holding Sema4 is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how SMFR fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Similar companies

Frequently asked questions

What is the ticker symbol for Sema4?

Sema4 trades under the ticker SMFR on NASDAQ.

Which exchange is SMFR listed on?

SMFR is listed on NASDAQ.

What sector does Sema4 operate in?

Sema4 is classified in the Healthcare sector (Medical - Healthcare Information Services industry).

How can PortView help analyze SMFR in a portfolio?

PortView shows SMFR's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.